prostate cancer active surveillance in 2019
Published 5 years ago • 4K plays • Length 9:14Download video MP4
Download video MP3
Similar videos
-
9:15
point-counterpoint: active surveillance for intermediate-risk prostate cancer - pro
-
11:13
active surveillance in favorable intermediate-risk prostate cancer
-
20:50
active surveillance 2021 - from bench to bedside
-
6:09
germline testing for prostate cancer active surveillance
-
20:23
active surveillance criteria and follow-up protocol
-
28:33
active surveillance results and implications of prospective studies
-
29:23
how should we monitor patients during surveillance?
-
1:00
treatment issues| #activesurveillance #prostatecancer #aspi #gleason6
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
23:37
active surveillance who is the right patient and what is the right protocol
-
9:59
point-counterpoint: active surveillance for intermediate-risk prostate cancer - con
-
20:39
active surveillance or: shrinking the gray zone
-
1:11
dr. david crawford discusses active surveillance in prostate cancer
-
40:52
global grand rounds: active surveillance for prostate cancer with matthew e. nielsen, md, ms, facs
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
17:45
point-counterpoint: oncotype dx genomic prostate score in active surveillance – canary pass study
-
1:24
dr. harris on psa testing and active surveillance in prostate cancer
-
1:58
integrated diagnostics and patient selection for active surveillance and treatment
-
9:27
role of mr-targeted prostate biopsy in active surveillance